Myeloid-specific krüppel-like factor 2 inactivation increases macrophage and neutrophil adhesion and promotes atherosclerosis

Circulation Research

Volumn 110, Issue 10, 2012, Pages 1294-1302

  Lingrel, Jerry B ^a   Pilcher Roberts, Robyn ^a   Basford, Joshua E ^a   Manoharan, Palanikumar ^b   Neumann, Jon ^a   Konaniah, Eddy S ^a   Srinivasan, Ramprasad ^a   Bogdanov, Vladimir Y ^a   Hui, David Y ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b NONE

Author keywords

atherosclerosis; Kr ppel like factor; neutrophils; oxidative stress

Indexed keywords

CRE RECOMBINASE; EPITOPE; KRUPPEL LIKE FACTOR 2; MYELOPEROXIDASE; TYROSINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROSCLEROSIS; CELL ADHESION; CELL CULTURE; CELL SURVIVAL; CHLORINATION; CHOLESTEROL DIET; CONTROLLED STUDY; DISEASE COURSE; ENDOTHELIUM CELL; FEMALE; GENE EXPRESSION; HYPERCHOLESTEROLEMIA; KNOCKOUT MOUSE; LIPID DIET; LIPID STORAGE; LYMPHOCYTE COUNT; MACROPHAGE ACTIVATION; MALE; MOUSE; NEUTROPHIL; NITROSYLATION; NONHUMAN; OXIDATIVE STRESS; POLARIZATION; PRIORITY JOURNAL;

ANIMALS; ATHEROSCLEROSIS; CELL ADHESION; CELL DEATH; ENDOTHELIAL CELLS; FEMALE; HYPERCHOLESTEROLEMIA; KRUPPEL-LIKE TRANSCRIPTION FACTORS; LYMPHOCYTE COUNT; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEUTROPHILS; VASCULITIS;

EID: 84861096946     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.112.267310     Document Type: Article

References (63)

1. Kuo CT, Veselits ML, Barton KP, Lu MM, Clendenin C, Leiden JM. The LKLF transcription factor is required for normal tunica media formation and blood vessel stabilization during murine embryogenesis. Genes Dev. 1997;11:2996-3006. (Pubitemid 27508510)
2. Wani MA, Means RT Jr, Lingrel JB. Loss of LKLF function results in embryonic lethality in mice. Transgenic Res. 1998;7:229-238. (Pubitemid 28541847)
3. Lee JS, Yu Q, Shin JT, Sebzda E, Bertozzi C, Chen M, Mericko P, Stadtfeld M, Zhou D, Cheng L, Graf T, MacRae CA, Lepore JJ, Lo CW, Kahn ML. KLF2 is an essential regulator of vascular hemodynamic forces in vivo. Dev Cell. 2006;11:845-857. (Pubitemid 44804271)
4. Atkins GB, Wang Y, Mahabeleshwar GH, Shi H, Gao H, Kawanami D, Natesan V, Lin Z, Simon DI, Jain MK. Hemizygous deficiency of Kruppel-like factor 2 augments experimental atherosclerosis. Circ Res. 2008;103:690-693.
5. Dekker RJ, van Thienen JV, Rohlena J, de Jager SC, Elderkamp YW, Seppen J, de Vries CJ, Biessen EA, van Berkel TJ, Pannekoek H, Horrevoets AJ. Endothelial KLF2 links local arterial shear stress levels to the expression of vascular tone-regulating genes. Am J Pathol. 2005;167: 609-618. (Pubitemid 43026114)
6. Huddleson JP, Srinivasan S, Ahmad N, Lingrel JB. Fluid shear stress induces endothelial KLF2 gene expression through a defined promoter region. J Biol Chem. 2004;385:723-729. (Pubitemid 39255630)
7. Ahmad N, Lingrel JB. Kruppel-like factor 2 transcriptional regulation involves heterogeneous nuclear ribonucleoproteins and acetyltransferases. Biochemistry. 2005;44:6276-6285. (Pubitemid 40570721)
8. Huddleson JP, Ahmad N, Lingrel JB. Up-regulation of the KLF2 transcription factor by fluid shear stress requires nucleolin. J Biol Chem. 2006;281:15121-15128. (Pubitemid 43855101)
9. Kumar A, Lin Z, SenBanerjee S, Jain MK. Tumor necrosis factor-α alpha-mediated reduction of KLF2 is due to inhibition of MEF2 by NF-ΚB and histone deacetylases. Mol Cell Biol. 2005;25:5893-5903. (Pubitemid 40946546)
10. Dekker RJ, van Soest S, Fontijn RD, Salamanca S, de Groot PG, VanBavel E, Pannekoek H, Horrevoets AJ. Prolonged fluid shear stress induces a distinct set of endothelial cell genes, most specifically lung Kruppel-like factor (KLF2). Blood. 2002;100:1689-1698. (Pubitemid 34925146)
11. Parmar KM, Larman HB, Dai G, Zhang Y, Wang ET, Moorthy SN, Kratz JR, Lin Z, Jain MK, Gimbrone MA Jr, Garcia-Cardena G. Integration of flow-dependent endothelial phenotypes by Kruppel-like factor 2. J Clin Invest. 2006;116:49-58. (Pubitemid 43121790)
12. Lin Z, Kumar A, SenBanerjee S, Staniszewski K, Parmar K, Vaughan DE, Gimbrone MA Jr, Balasubramanian V, Garcia-Cardena G, Jain MK. Kruppel-like factor 2 (KLF2) regulates endothelial thrombotic function. Circ Res. 2005;96:e48-e57.
13. SenBanerjee S, Lin Z, Atkins GB, Greif DM, Rao RM, Kumar A, Feinberg MW, Chen Z, Simon DI, Luscinskas FW, Michel TM, Gimbrone MA Jr, Garcia-Cardena G, Jain MK. KLF2 is a novel transcriptional regulator of endothelial proinflammatory activation. J Exp Med. 2004;199:1305-1315. (Pubitemid 38685723)
14. Lin Z, Hamik A, Jain R, Kumar A, Jain MK. Kruppel-like factor 2 inhibits protease activated receptor-1 expression and thrombin-mediated endothelial activation. Arterioscler Thromb Vasc Biol. 2006;26: 1185-1189. (Pubitemid 43732131)
15. Carlson CM, Endrizzi BT, Wu J, Ding X, Weinreich MA, Walsh ER, Wani MA, Lingrel JB, Hogquist KA, Jameson SC. Kruppel-like factor 2 regulates thymocyte and T-cell migration. Nature. 2006;442: 299-302. (Pubitemid 44114904)
16. Das H, Kumar A, Lin Z, Patino WD, Hwang PM, Feinberg MW, Majumder PK, Jain MK. Kruppel-like factor 2 (KLF2) regulates proinflammatory activation of monocytes. Proc Natl Acad Sci U S A. 2006; 103:6653-6658.
17. Cao Z, Sun X, Icli B, Wara AK, Feinberg MW. Role of Kruppel-like factors in leukocyte development, function, and disease. Blood. 2010; 116:4404-4414.
18. Bu DX, Tarrio M, Grabie N, Zhang Y, Yamazaki H, Stavrakis G, Maganto-Garcia E, Pepper-Cunningham Z, Jarolim P, Aikawa M, Garcia- Cardena G, Lichtman AH. Statin-induced Kruppel-like factor 2 expression in human and mouse T cells reduces inflammatory and pathogenic responses. J Clin Invest. 2010;120:1961-1970.
19. Feinberg MW, Cao Z, Wara AK, Lebedeva MA, Senbanerjee S, Jain MK. Kruppel-like factor 4 is a mediator of proinflammatory signaling in macrophages. J Biol Chem. 2005;280:38247-38258. (Pubitemid 43853721)
20. Feinberg MW, Wara AK, Cao Z, Lebedeva MA, Rosenbauer F, Iwasaki H, Hirai H, Katz JP, Haspel RL, Gray S, Akashi K, Segre J, Kaestner KH, Tenen DG, Jain MK. The Kruppel-like factor klf4 is a critical regulator of monocyte differentiation. EMBO J. 2007;26:4138-4148. (Pubitemid 47462091)
21. Zernecke A, Bot I, Djalali-Talab Y, Shagdarsuren E, Bidzhekov K, Meiler S, Krohn R, Schober A, Sperandio M, Soehnlein O, Bornemann J, Tacke F, Biessen EA, Weber C. Protective role of CXC receptor 4/CXC ligand 12 unveils the importance of neutrophils in atherosclerosis. Circ Res. 2008;102:209-217. (Pubitemid 351651125)
22. Zahorec R. Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill. Bratisl Lek Listy. 2001;102:5-14.
23. Duffy BK, Gurm HS, Rajagopal V, Gupta R, Ellis SG, Bhatt DL. Usefulness of an elevated neutrophil to lymphocyte ratio in predicting long-term mortality after percutaneous coronary intervention. Am J Cardiol. 2006;97:993-996.
24. Hansson GK, Robertson A-KL, Soderberg-Naucler C. Inflammation and atherosclerosis. Annu Rev Pathol Mech Dis. 2006;1:297-329.
25. Terashima T, English D, Hogg JC, van Eeden SF. Release of polymorphonuclear leukocytes from the bone marrow by interleukin-8. Blood. 1998;92:1062-1069. (Pubitemid 28355491)
26. Ueda Y, Yang K, Foster SJ, Kondo M, Kelsoe G. Inflammation controls B lymphopoiesis by regulating chemokine CXCL12 expression. J Exp Med. 2004;199:47-58.
27. Uedo Y, Kondo M, Kelsoe G. Inflammation and the reciprocal production of granulocytes and lymphocytes in bone marrow. J Exp Med. 2005;201: 1771-1780. (Pubitemid 41002896)
28. Zhu X, Lee J-Y, Timmins JM, Brown JM, Boudyguina E, Mulya A, Gebre AK, Willingham MC, Hiltbold EM, Mishra N, Maeda N, Parks JS. Increased cellular free cholesterol in macrophage-specific ABCA1 knock-out mice enhances pro-inflammatory response of macrophages. J Biol Chem. 2008;283:22930-22941.
29. Seimon TA, Wang Y, Han S, Senokuchi T, Schrijvers DM, Kuriakose G, Tall AR, Tabas IA. Macrophage deficiency of p38α MAPK promotes apoptosis and plaque necrosis in advanced atherosclerotic lesions in mice. J Clin Invest. 2009;119:886-898.
30. Kardakaris R, Gareus R, Xanthoulea S, Pasparakis M. Endothelial and macrophage-specific deficiency of p38α mapk does not affect the pathogenesis of atherosclerosis in apoE-/- mice. PLoS One. 2011;6: e21055.
31. Paigen B, Morrow A, Holmes PA, Mitchell D, Williams RA. Quantitative assessment of atherosclerotic lesions in mice. Atherosclerosis. 1987;68: 231-240. (Pubitemid 17159775)
32. Tangirala R, Rubin E, Palinski W. Quantitation of atherosclerosis in murine models: correlation between lesions in the aortic origin and in the entire aorta, and differences in the extent of lesions between sexes in LDL receptor-deficient and apolipoprotein E-deficient mice. J Lipid Res. 1995; 36:2320-2328.
33. Lo S, Van Seventer G, Levin S, Wright S. Two leukocyte receptors (CD11a/CD18 and CD11b/CD18) mediate transient adhesion to endothelium by binding to different ligands. J Immunol. 1989;143: 3325-3329. (Pubitemid 20010163)
34. Coxon A, Rieu P, Barkalow FJ, Askari S, Sharpe AH, von Andrian UH, Arnaout MA, Mayadas TN. A novel role for the β2 integrin CD11b/CD18 in neutrophil apoptosis: A homeostatic mechanism in inflammation. Immunity. 1996;5:653-666. (Pubitemid 27062073)
35. Walzog B, Jerblonski F, Zakzewicz A, Gaehtgens P. β2 Integrins (CD11/CD18) promote apoptosis of human neutrophils. FASEB J. 1997; 11:1177-1186. (Pubitemid 27481442)
36. Nicholls SJ, Hazen SL. Myeloperoxidase and cardiovascular disease. Arterioscler Thromb Vasc Biol. 2005;25:1102-1111. (Pubitemid 40776595)
37. Kuo CT, Leiden JM. Transcriptional regulation of T lymphocyte development and function. Annu Rev Immunol. 1999;17:149-187. (Pubitemid 29241122)
38. Kuo CT, Veselits ML, Leiden JM. Lklf: A transcriptional regulator of single-positive T cell quiescence and survival. Science. 1997;277: 1986-1990. (Pubitemid 27449139)
39. Buckley AF, Kuo CT, Leiden JM. Transcription factor LKLF is sufficient to program T cell quiescence via a c-myc-dependent pathway. Nat Immunol. 2001;2:698-704. (Pubitemid 32747158)
40. Wu J, Lingrel JB. KLF2 inhibits jurkat T leukemia cell growth via upregulation of cyclin-dependent kinase inhibitor p21WAF1/CIP1. Oncogene 2004;23:8088-8096. (Pubitemid 39531849)
41. Haaland RE, Yu W, Rice AP. Identification of LKLF-regulated genes in quiescent CD4+ T lymphocytes. Mol Immunol. 2005;42:627-641. (Pubitemid 39655940)
42. Bai A, Hu H, Yeung M, Chen J. Kruppel-like factor 2 controls T cell trafficking by activating l-selectin (CD62l) and sphingosine-1-phosphate receptor 1 transcription. J Immunol. 2007;178:7632-7639. (Pubitemid 46898033)
43. Sebzda E, Zou Z, Lee JS, Wang T, Kahn ML. Transcription factor KLF2 regulates the migration of naive T cells by restricting chemokine receptor expression patterns. Nature Immunology. 2008;9:292-300. (Pubitemid 351267326)
44. Banerjee SS, Feinberg MW, Watanabe M, Gray S, Haspel RL, Denkinger DJ, Kawahara R, Hauner H, Jain MK. The Kruppel-like factor KLF2 inhibits peroxisome proliferator-activated receptor-γ expression and adipogenesis. J Biol Chem. 2003;278:2581-2584. (Pubitemid 36801336)
45. Basu P, Morris PE, Haar JL, Wani MA, Lingrel JB, Gaensler KM, Lloyd JA. KLF2 is essential for primitive erythropoiesis and regulates the human and murine embryonic β-like globin genes in vivo. Blood. 2005; 106:2566-2571. (Pubitemid 41510835)
46. Basu P, Lung TK, Lemsaddek W, Sargent TG, Williams DC Jr, Basu M, Redmond LC, Lingrel JB, Haar JL, Lloyd JA. EKLF and KLF2 have compensatory roles in embryonic β-globin gene expression and primitive erythropoiesis. Blood. 2007;110:3417-3425. (Pubitemid 350106337)
47. Mantovani A, Garlanda C, Locati M. Macrophage diversity and polarization in atherosclerosis. Arterioscler Thromb Vasc Biol. 2009;29: 1419-1423.
48. Soehnlein O, Lindbom L. Phagocyte partnership during the onset and resolution of inflammation. Nat Rev Immunol. 2010;10:427-439.
49. Baetta R, Corsini A. Role of polymorphonuclear neutrophils in atherosclerosis: current state and future perspectives. Atherosclerosis. 2010; 210:1-13.
50. Clausen BE, Burkhardt C, Reith W, Renkawitz R, Forster I. Conditional gene targeting in macrophages and granulocytes using lysMcre mice. Transgenic Res. 1999;8:265-277. (Pubitemid 29523965)
51. Li CY, Zhan YQ, Li W, Xu CW, Xu WX, Yu DH, Peng RY, Cui YF, Yang X, Hou N, Li YH, Dong B, Sun HB, Yang XM. Overexpression of a hematopoietic transcriptional regulator EDAG induces myelopoiesis and suppresses lymphopoiesis in transgenic mice. Leukemia. 2007;21: 2277-2286. (Pubitemid 350011700)
52. Libby P, Ridker PM, Hansson GK. Inflammation in atherosclerosis. J Am Coll Cardiol. 2009;54:2129-2138.
53. Drechsler M, Megens RTA, van Zandvoort M, Weber C, Soehnlein O. Hyperlipidemia-triggered neutrophilia promotes early atherosclerosis. Circulation. 2010;122:1837-1845.
54. Soehnlein O, Weber C. Myeloid cells in atherosclerosis: initiators and decision shapers. Semin Immunopathol. 2009;31:35-47.
55. Ali F, Hamdulay SS, Kinderlerer AR, Boyle JJ, Lidington EA, Yamaguchi T, Soares MP, Haskard DO, Randi AM, Mason JC. Statinmediated cytoprotection of human vascular endothelial cells: A role for Kruppel-like factor 2-dependent induction of heme oxygenase-1. J Thromb Haemost 2007;5:2537-2546. (Pubitemid 350154366)
56. Parmar KM, Nambudiri V, Dai G, Larman HB, Gimbrone MA Jr, Garcia- Cardena G. Statins exert endothelial atheroprotective effects via the KLF2 transcription factor. J Biol Chem. 2005;280:26714-26719. (Pubitemid 41040703)
57. Tuomisto TT, Lumivuori H, Kansanen E, Hakkinen S-K, Turunen MP, van Thienen JV, Horrevoets AJ, Levonen A-L, Yla-Herttuala S. Simvastatin has an anti-inflammatory effect on macrophages via upregulation of an atheroprotective transcription factor, Kruppel-like factor 2. Cardiovasc Res. 2008;78:175-184. (Pubitemid 351430960)
58. Van Oostrom AJHHM, Plokker HWM, Van Asbeck BS, Rabelink TJ, van Kessel KPM, Jansen EHJM, Stehouwer CDA, Cabezas MC. Effects of rosuvastatin on postprandial leukocytes in mildly hyperlipidemic patients with premature coronary sclerosis. Atherosclerosis. 2006;185:331-339.
59. Walter T, Suselbeck T, Borggrefe M, Swoboda S, Hoffmeister HM, Dempfle CE. Effect of atovastatin on cellular adhesion molecules on leukocytes in patients with normocholesterolemic coronary artery disease. In Vivo. 2010;24:189-193.
60. Sugano R, Matsuoka H, Haramaki N, Umei H, Murase E, Fukami K, Iida S, Ikeda H, Imaizumi T. Polymorphonuclear leukocytes may impair endothelial function: Results of crossover randomized study of lipid-lowering therapies. Arterioscler Thromb Vasc Biol. 2005;25:1262-1267. (Pubitemid 40776619)
61. Guasti L, Marino F, Cosentino M, Cimpanelli M, Maio RC, Klersy C, Crespi C, Restelli D, Simoni C, Franzetti I, Gaudio G, Marnini P, Grandi AM, Lecchini S, Venco A. Simvastatin treatment modifies polymorphonuclear leukocyte function in high-risk individuals: A longitudinal study. J Hypertens. 2006;24:2423-2430. (Pubitemid 44684691)
62. Guasti L, Marino F, Cosentino M, Maio RC, Rasini E, Ferrari M, Castiglioni L, Klersy C, Gaudio G, Grandi AM, Lecchini S, Venco A. Prolonged statin-associated reduction in neutrophil reactive oxygen species and angiotensin II type 1 receptor expression: 1-year follow-up. Eur Heart J. 2008;29:1118-1126. (Pubitemid 351844894)
63. Maher BM, Dhonnchu TN, Burke JP, Soo A, Wood AE, Watson RW. Statins alter neutrophil migration by modulating cellular rho activity: A potential mechanism for statins-mediated pleotropic effects? J Leukoc Biol. 2009;85:186-193.